Biotech Values

[turtlepower]

HCV - The Waiting Game
In the next year, the expected approval of small molecules targeting hepatitis C will usher in a new era in treatment
Lisa M. Jarvis

http://pubs.acs.org/cen/coverstory/88/8818cover.html